Skip to content
MICA Biosystems logo — An innovative and dynamic biotech start-up, unlocking the po...

MICA Biosystems

An innovative and dynamic biotech start-up, unlocking the potential of stem cells and nanotechnology in medicine.

Founded 2011 United Kingdom London, United Kingdom 9 employees Grant Total: $2.11M Biotechnology, Health Care +2

General Information

Company Name MICA Biosystems
Founded Year 2011
Location United Kingdom London, United Kingdom
Employees 9
Industries Biotechnology, Health Care, Life Sciences +1
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with MICA Biosystems. To contact MICA Biosystems, visit micabiosystems.co.uk.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does MICA Biosystems compare?

A PDF of MICA Biosystems and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting MICA Biosystems soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About MICA Biosystems

MICA Biosystems is a biotech startup that leverages nanotechnology for regenerative medicine, advanced therapies, drug discovery, and 3D organoid cell culture, boasting a substantial patent portfolio. The company is currently seeking Series A Venture investment to accelerate its clinical trials. Founded in 2011, MICA Biosystems has a diverse product/therapy portfolio, reflecting extensive R&D efforts by world-class researchers in biotechnology, cell engineering, regenerative medicine, and bioengineering. The company's main offerings include MICA Cell Therapy, which utilizes nanoparticles and induced magnetic fields for highly accurate control of stem cell differentiation in vivo, primarily targeting spinal repair. Additionally, Dynascreen™ aims to provide mechanical stimulation to cells in drug screening assays, mimicking in vivo environments with low cost and high efficacy. The MICA Bioreactor employs nanotechnology and magnetic forces to facilitate 3D structure and organoid cell cultures with patented instrumentation. Having received a $350.00K grant investment in December 2021, the company showcases promising advancements in the biotechnology, healthcare, life sciences, and medical devices industries, positioning itself as an innovative and dynamic player in the biotech sector.

Business keywords: Biotech, Stem Cell Therapy, Nanotechnology, Regenerative Medicine, Drug Discovery, 3D Organoid Cell Culture, Cell Engineering, Bioengineering, Nanomedicine, Advanced Therapy, R&D, Biomedicine, Magnetic Nanoparticles, Clinical Trials, Spinal Repair

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $350.00K -
20 Dec 2021
Grant Undisclosed -
01 Nov 2021
Grant $140.00K 1
Innovate UK
02 Oct 2014
Grant $120.00K 1
European Commission
02 Nov 2013
Pre Seed Round $1.50M -
01 Dec 2010

MICA Biosystems Alternatives & Competitors

View All Alternatives
MICA Biosystems vs

BreStem is a clinical stage biotech company working to fight deadly lung diseases through stem cell...

1 employees
Biotechnology, Health Care
MICA Biosystems vs
Emmecell
Emmecell United States

Magnetic Cell Delivery Platform for Cell Therapy

11 employees
Biotechnology, Health Care
MICA Biosystems vs

BrainStorm Cell Therapeutics Inc. (NASDAQ) develops autologous stem cell therapies for neurodegenera...

Post-IPO Equity
36 employees
Biotechnology, Health Care

FAQ About MICA Biosystems

An innovative and dynamic biotech start-up, unlocking the potential of stem cells and nanotechnology in medicine.
MICA Biosystems was founded in 2011.
MICA Biosystems is headquartered in London, United Kingdom.
MICA Biosystems operates in Biotechnology, Health Care, Life Sciences and Medical Devices. Its work centres on Biotech, Stem Cell Therapy, Nanotechnology and Regenerative Medicine.
MICA Biosystems has approximately 9 employees.
MICA Biosystems has completed 5 funding rounds, raising a total of $2.11M. The latest funding stage is Grant.
Top alternatives and competitors to MICA Biosystems include BreStem Therapeutics, Inc., Emmecell, Brainstorm Cell Therapeutics, PrimeCell Bioscience, a.s., CytoNiche. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MICA Biosystems and BreStem Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for MICA Biosystems, https://bouncewatch.com/company/mica-biosystems, updated 19 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout